FDC secures USFDA’s nod for Fluconazole Tablets
The company has received abbreviated new drug application approval from USFDA
FDC has received abbreviated new drug application (ANDA) approval from United States Food and Drug Administration (USFDA) for Fluconazole Tablets USP, 50 mg, 100 mg, 150 mg and 200 mg.
Earlier, the company had secured ANDA approval from United States Food and Drug Administration (USFDA), for Pilocarpine Hydrochloride Ophthalmic Solution USP, 1%, 2%, and 4% (15 mL).
FDC is among India’s leading fully integrated pharmaceutical companies.
